Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/10/15 → 4/30/20 |
Funding
- Covance Inc. (Prot #BO29337)
- Genentech, Inc. (Prot #BO29337)
Prot #BO29337: A Phase II, Open-Label Study Evaluating the Safety and Efficacy of GDC-0199 (ABT-199) Plus Bendamustine Plus Rituximab (BR) in Comparison with BR Alone or GDC-0199 Plus Rituximab (R) in Patients with Relapsed and Refractory Follicular Non-H
- Pro, Barbara (PD/PI)
Project: Research project